cyclohexanol has been researched along with Acute Brain Injuries in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, R; Brodhun, M; Brust, P; Deuther-Conrad, W; Donat, CK; Fischer, F; Walter, B | 1 |
| Katiyar, S; Kukade, G; Mahesh, R; Pandey, DK; Rudra, A; Viyogi, S | 1 |
| Amenta, PS; Barbe, MF; Elliott, MB; Jallo, JI; Tuma, RF | 1 |
| Amenta, PS; Elliott, MB; Jallo, JI; Tuma, RF | 1 |
| Ding, BK; Jin, KH; Ma, H; Qin, XS; Xie, SF | 1 |
| De Vry, J; Horváth, E; Mauler, F; Mittendorf, J | 1 |
6 other study(ies) available for cyclohexanol and Acute Brain Injuries
| Article | Year |
|---|---|
Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet.
Topics: Analysis of Variance; Animals; Animals, Newborn; Autoradiography; Brain; Brain Injuries; Cannabinoid Receptor Modulators; Cyclohexanols; Disease Models, Animal; Female; Isoquinolines; Piperidines; Protein Binding; Pyrazoles; Radionuclide Imaging; Receptors, Cannabinoid; Receptors, GABA; Rimonabant; Swine; Time Factors; Tritium | 2014 |
Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats.
Topics: Acceleration; Amitriptyline; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain Injuries; Bupropion; Citalopram; Cyclohexanols; Exploratory Behavior; Fear; Male; Neuronal Plasticity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Wistar; Reflex, Startle; Serotonin; Social Behavior; Venlafaxine Hydrochloride | 2010 |
Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury.
Topics: Animals; Anisoles; Brain Injuries; Cannabinoid Receptor Modulators; Cyclohexanols; Disease Models, Animal; Inflammation; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Neurons; Receptor, Cannabinoid, CB2; Resorcinols | 2011 |
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury.
Topics: Animals; Anisoles; Blood-Brain Barrier; Brain Injuries; Cyclohexanols; Drug Evaluation, Preclinical; Exploratory Behavior; Macrophages; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurons; Neuroprotective Agents; Receptor, Cannabinoid, CB2; Rotarod Performance Test; Wounds, Nonpenetrating | 2012 |
Effects of extract of Ginkgo biloba with venlafaxine on brain injury in a rat model of depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain Injuries; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Drugs, Chinese Herbal; Ginkgo biloba; Hippocampus; Male; Phytotherapy; Rats; Rats, Wistar; Venlafaxine Hydrochloride | 2005 |
Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.
Topics: Animals; Binding, Competitive; Body Temperature; Brain Injuries; Brain Ischemia; Cyclohexanols; Discrimination, Psychological; Guanosine 5'-O-(3-Thiotriphosphate); Hematoma, Subdural; Indans; Male; Middle Cerebral Artery; Neuroprotective Agents; Rats; Rats, Long-Evans; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Succinate Dehydrogenase; Sulfonic Acids | 2002 |